Rigmor Solberg Selected Research

Rigmor Solberg Research Topics

5	Neoplasms (Cancer) 12/2022 - 01/2010
3	Atherosclerosis 01/2020 - 01/2017
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2022 - 11/2019
2	Carotid Artery Diseases 01/2020 - 01/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2020
2	Atherosclerotic Plaque (Atheroma) 01/2017 - 07/2014
2	Colorectal Neoplasms (Colorectal Cancer) 07/2014 - 01/2013
2	Pathologic Processes 04/2013 - 01/2013
2	Neoplasm Metastasis (Metastasis) 04/2013 - 01/2010
1	Fibrosis (Cirrhosis) 12/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2022
1	Reperfusion Injury 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	ST Elevation Myocardial Infarction 01/2020
1	Myocardial Infarction 01/2020
1	Stroke (Strokes) 01/2020
1	Acute Coronary Syndrome 01/2020
1	Osteoporosis 11/2019
1	Peptic Ulcer (Peptic Ulcers) 08/2019
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2017
1	Postmenopausal Osteoporosis 01/2017
1	Pathologic Constriction (Stenosis) 01/2017
1	Hypercholesterolemia 01/2014
1	Myotoxicity 01/2014
1	Melanoma (Melanoma, Malignant) 01/2010
1	Breast Neoplasms (Breast Cancer) 01/2010
1	Sepsis (Septicemia) 03/2003
1	Staphylococcal Infections 05/2002

11	asparaginylendopeptidase (legumain)IBA 12/2022 - 01/2010
7	Cysteine Proteases (Cysteine Protease)IBA 01/2020 - 01/2010
2	ProdrugsIBA 08/2019 - 07/2014
1	Complement System Proteins (Complement)IBA 01/2022
1	Proton Pump InhibitorsIBA 08/2019
1	EnzymesIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	ImmunosorbentsIBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014
1	Simvastatin (Zocor)FDA LinkGeneric 01/2014
1	Peptide Hydrolases (Proteases)FDA Link 01/2013
1	Histones (Histone)IBA 01/2013
1	Cathepsin BIBA 01/2010
1	Cystatin MIBA 01/2010
1	matrigelIBA 01/2010
1	CathepsinsIBA 01/2010
1	Cystatin CIBA 01/2010
1	Cysteine Proteinase InhibitorsIBA 01/2010
1	LipopolysaccharidesIBA 03/2003
1	CytokinesIBA 05/2002

1	Percutaneous Coronary Intervention 01/2020